← SynDRA
ATN-161
SynDRA canonical compound SYN0086780 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ITGB3 |
|---|
| Mechanism of action | Integrin inhibitor |
|---|
All known targets
- ITGA5
- ITGAV
- ITGB1
- ITGB3
- ITGA5-ITGB1
- ITGAV-ITGB3
- ITGB5
Mechanisms of action (all sources)
- Integrin inhibitor
- ITGB1 ANTAGONIST
- Integrin alpha-5/beta-1 antagonist
- ITGA5 ANTAGONIST
- ITGB3 ANTAGONIST
- Integrin alpha-V/beta-3 antagonist
- ITGAV ANTAGONIST
- integrin antagonist
- Antagonist
Cross-references
Synonyms
- ATN 161
- Ac-phscn-nh2
- PHSCN
- PHSCN, University of Michigan
- Angiogenesis inhibitors (cancer), Attenuon
- Integrin antagonists (cancer), Attenuon
- Ac-PHSCN-NH2, University of Michigan
- Ac-PHSCN-NH2
- XW0H5LE42K
- RefChem:115440
- DTXCID00103368
- Alpha V Beta 1 Inhibitor ATN-161
- ATN-161 free base
- UNII-XW0H5LE42K
- orb1710371
- SCHEMBL2157375
- SCHEMBL17262996
- C23H35N9O8S
- GLXC-04869
- ATN-161?
- ATN-161 (Ac-PHSCN-NH2)
- ?MKA43843
- EX-A12720
- s8454
- AKOS030210988
- AKOS040732486
- CCG-270186
- CS-3327
- NCGC00390546-01
- BS-16323
- DA-71103
- HY-13535
- D83668
- T10398
- Acetyl-prolyl-histidyl-seryl-cysteinyl-asparaginamide
- BRD-K00521308-019-01-9
- (2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-acetylpyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-sulfanylpropanoyl]amino]butanediamide
Look up ATN-161 in the interactive SynDRA portal →